Journey Medical (DERM) Total Current Liabilities (2020 - 2026)

Journey Medical's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $37.8 million for Q1 2026.

• Quarterly Total Current Liabilities fell 5.95% year-over-year to $37.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.8 million (down 5.95% YoY) and the FY2025 annual result came in at $37.4 million, up 6.44% from the prior year.
• Total Current Liabilities was $37.8 million for Q1 2026 at Journey Medical, up from $37.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $76.9 million in Q1 2023 and bottomed at $33.3 million in Q3 2024.
• A 5-year average of $48.3 million and a median of $40.5 million in 2025 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities grew 29.48% — and 2024, when it plunged 49.93%.
• Journey Medical's Total Current Liabilities stood at $66.8 million in 2022, then plunged by 37.35% to $41.9 million in 2023, then fell by 15.99% to $35.2 million in 2024, then advanced by 6.44% to $37.4 million in 2025, then grew by 1.04% to $37.8 million in 2026.
• Business Quant data shows DERM's Total Current Liabilities at $37.8 million in Q1 2026, $37.4 million in Q4 2025, and $39.7 million in Q3 2025.